Change of Lipoprotein(a) and Coagulathre or Fibrinolytic Parameters in Diabetic Patients with Nephropathy

Nagai, Takashi; Tomizawa, Takashi; Mori, Masatomo

doi:10.2337/diacare.16.10.1411b

Article navigation

Letters| October 01 1993

Change of Lipoprotein(a) and Coagulathre or Fibrinolytic Parameters in Diabetic Patients with Nephropathy

Takashi Nagai, MD;

Takashi Nagai, MD

First Department of Internal Medicine, Gunma University School of Medicine

Gunma

;

Maebashi and the Department of Internal Medicine, Public Tomioka General Hospital

Gunma, Japan

Search for other works by this author on:

This Site

PubMed

Google Scholar

Takashi Tomizawa, MD;

Takashi Tomizawa, MD

First Department of Internal Medicine, Gunma University School of Medicine

Gunma

;

Maebashi and the Department of Internal Medicine, Public Tomioka General Hospital

Gunma, Japan

Search for other works by this author on:

This Site

PubMed

Google Scholar

Masatomo Mori, MD

First Department of Internal Medicine, Gunma University School of Medicine

Gunma

;

Maebashi and the Department of Internal Medicine, Public Tomioka General Hospital

Gunma, Japan

Search for other works by this author on:

This Site

PubMed

Google Scholar

Address correspondence to Takashi Nagai, Department of Internal Medicine, Public Tomioka General Hospital, 2073–1 Tomioka, Tomioka, Gunma, 370–23, Japan.

Diabetes Care 1993;16(10):1411–1412

https://doi.org/10.2337/diacare.16.10.1411b

PubMed:

8269808

Change of Lipoprotein(a) and Coagulathre or Fibrinolytic Parameters in Diabetic Patients with Nephropathy

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Change of Lipoprotein(a) and Coagulathre or Fibrinolytic Parameters in Diabetic Patients with Nephropathy Free

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only

Change of Lipoprotein(a) and Coagulathre or Fibrinolytic Parameters in Diabetic Patients with Nephropathy